Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Earnings Call

P3 Health Partners Earnings Call: Key Takeaways

P3 Health Partners achieved its third consecutive profitable quarter, raising full-year Adjusted EBITDA guidance midpoint to $100 million while highlighting a $200 million value creation pipeline.

Full earnings call on the Alfa Finder USA YouTube channel · Open on YouTube ↗
Highlights
Revenue GrowthTotal revenue $345 million, up 15% year-over-year; capitated revenue up 18%.
Mgmt ConfidenceHigh confidence citing 'durable foundation' and three consecutive profitable quarters.
Demand VisibilityStrong demand from 60 mid-sized Medicare Advantage plans for P3's model.
Order BookAt-risk membership at 105,000; 28,000 lives in management services pipeline.
Margin TrendsMedical margin $44 million; 90.6% MLR adjusted for prior period items.
Op. LeverageGrowth in existing markets adds membership at low incremental cost.
Pricing PowerImproved payer economics and 18% increase in capitated revenue per member.
Vol vs PriceGrowth driven by 18% rate progression and improved payer economics.
Segment GrowthNebraska market launch in May 2026 serving as new growth model.
New ClientsAdded 23 clinicians to P3 Restore; expanding delegated functions with payers.
Capex & DebtActively managing liquidity; cash and equivalents at $61 million.
RegulatoryRecognized $7 million favorable medical margin from 2025 CMS-ACO reconciliation.
CommentaryFocusing on 'margin first, membership growth after' to ensure sustainable economics.
New LaunchesLaunched Nebraska market; implementing utilization management and senior wellness centers.

Growth

Revenue rose 15% to $345 million; Adjusted EBITDA reached $21 million in Q3.

Outlook

Raised 2026 Adjusted EBITDA guidance to $90M-$110M; identified $200M potential value creation.

Risks

Management pivoted to vague 'multi-year' language when pressed for specific 2027 enrollment numbers.

Source

The company's earnings call, NASDAQ: PIII, and its 8-K filed with the SEC. Summary written with AI assistance from the call.

Read the 8-K ↗

P3 Health Partners Inc.: key numbers

Share price
$2.41Close, Nov 16
Sector
Industrial Applications and Services
Industry
Services-Health ServicesSIC 8000

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from P3 Health Partners Inc.

All →
4:48 PM ET 10-Q
Financial Results ▶ Call

P3 Health Partners Q3 2026 Results: Turns Profitable, Net Income $15.6M

P3 Health Partners Inc. reported its third quarter 2026 results, highlighting significant risks regarding its ability to continue as a going concern and the need for additional capital. The company continues to experience net losses and faces challenges maintaining compliance with debt covenants and Nasdaq listing requirements.

Key figure
Net income $15.6M
4:24 PM ET 8-K
Financial Results

P3 Health Partners Financial Results

P3 Health Partners reported Q3 2026 financial results with revenue of $396 million, up 15% year-over-year, and net income of $30.8 million. The company raised its full-year 2026 Adjusted EBITDA guidance midpoint to $100 million based on strong year-to-date performance and improved network economics.

Term
Q3 2026

“This was another strong quarter for P3. The foundation we have built over the past two years is showing up both in the care our patients receive and in the consistency of our results. We carry real momentum into 2027, as evidenced by our medical cost trend, and I am excited about what lies ahead for our patients, our providers, and our partners.”

Dr. Aric Coffman, CEO of P3

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.